{"id":"https://openalex.org/W7225620330","doi":"https://doi.org/10.1007/s11095-026-04234-w","title":"Transdermal Acetaminophen and Caffeine for Migraine, Part 1: Solid Microneedles and Co-loaded Polymeric Gels","display_name":"Transdermal Acetaminophen and Caffeine for Migraine, Part 1: Solid Microneedles and Co-loaded Polymeric Gels","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225620330","doi":"https://doi.org/10.1007/s11095-026-04234-w","pmid":"https://pubmed.ncbi.nlm.nih.gov/43004086"},"language":"en","primary_location":{"id":"doi:10.1007/s11095-026-04234-w","doi":"https://doi.org/10.1007/s11095-026-04234-w","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11095-026-04234-w","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11095-026-04234-w.pdf","source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s11095-026-04234-w.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5106660399","display_name":"Harsha Jain","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harsha Jain","raw_affiliation_strings":["Department of Pharmaceutical Sciences and Experimental Therapeutics, University of Iowa, Iowa City, IA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences and Experimental Therapeutics, University of Iowa, Iowa City, IA, USA","institution_ids":["https://openalex.org/I126307644"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083686261","display_name":"Nicole K. Brogden","orcid":"https://orcid.org/0000-0001-6838-8847","observed_orcids":["https://orcid.org/0000-0001-6838-8847"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Nicole K. Brogden","raw_affiliation_strings":["Department of Dermatology, Carver College of Medicine, University of Iowa, Iowa City, IA, USA. nicole-brogden@uiowa.edu","Department of Pharmaceutical Sciences and Experimental Therapeutics, University of Iowa, Iowa City, IA, USA. nicole-brogden@uiowa.edu"],"raw_orcid":"https://orcid.org/0000-0001-6838-8847","affiliations":[{"raw_affiliation_string":"Department of Dermatology, Carver College of Medicine, University of Iowa, Iowa City, IA, USA. nicole-brogden@uiowa.edu","institution_ids":["https://openalex.org/I126307644"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences and Experimental Therapeutics, University of Iowa, Iowa City, IA, USA. nicole-brogden@uiowa.edu","institution_ids":["https://openalex.org/I126307644"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5083686261"],"corresponding_institution_ids":["https://openalex.org/I126307644"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":{"value":4690,"currency":"USD","value_usd":4690},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/transdermal-drug-delivery","display_name":"transdermal drug delivery","score":0.8960000276565552},{"id":"https://openalex.org/keywords/paracetamol","display_name":"paracetamol","score":0.9610000252723694},{"id":"https://openalex.org/keywords/caffeine","display_name":"caffeine","score":1.0},{"id":"https://openalex.org/keywords/migraine","display_name":"migraine","score":0.8309999704360962},{"id":"https://openalex.org/keywords/solid-microneedles","display_name":"solid microneedles","score":0.9869999885559082},{"id":"https://openalex.org/keywords/polymer-gels","display_name":"polymer gels","score":0.8399999737739563},{"id":"https://openalex.org/keywords/hydroxyethyl-cellulose","display_name":"hydroxyethyl cellulose","score":0.9620000123977661},{"id":"https://openalex.org/keywords/polyvinylpyrrolidone","display_name":"polyvinylpyrrolidone","score":1.0},{"id":"https://openalex.org/keywords/drug-polymer-interactions","display_name":"drug-polymer interactions","score":0.800000011920929},{"id":"https://openalex.org/keywords/skin-permeation","display_name":"skin permeation","score":0.8159999847412109},{"id":"https://openalex.org/keywords/co-delivery","display_name":"co-delivery","score":0.6029999852180481},{"id":"https://openalex.org/keywords/skin-barrier-disruption","display_name":"skin barrier disruption","score":0.6589999794960022},{"id":"https://openalex.org/keywords/transepidermal-water-loss","display_name":"transepidermal water loss","score":0.9509999752044678},{"id":"https://openalex.org/keywords/porcine-skin","display_name":"porcine skin","score":0.625},{"id":"https://openalex.org/keywords/viscoelasticity","display_name":"viscoelasticity","score":0.5479999780654907}],"concepts":[{"id":"https://openalex.org/C50670333","wikidata":"https://www.wikidata.org/wiki/Q907651","display_name":"Permeation","level":3,"score":0.8411999940872192},{"id":"https://openalex.org/C205679159","wikidata":"https://www.wikidata.org/wiki/Q3375179","display_name":"Transdermal","level":2,"score":0.8374999761581421},{"id":"https://openalex.org/C2780077769","wikidata":"https://www.wikidata.org/wiki/Q413433","display_name":"Polyvinylpyrrolidone","level":2,"score":0.6678000092506409},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6355999708175659},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.5703999996185303},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.48730000853538513},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.42559999227523804},{"id":"https://openalex.org/C2778500429","wikidata":"https://www.wikidata.org/wiki/Q60235","display_name":"Caffeine","level":2,"score":0.4230000078678131},{"id":"https://openalex.org/C160892712","wikidata":"https://www.wikidata.org/wiki/Q901559","display_name":"Fourier transform infrared spectroscopy","level":2,"score":0.4138000011444092},{"id":"https://openalex.org/C95150158","wikidata":"https://www.wikidata.org/wiki/Q7833972","display_name":"Transepidermal water loss","level":3,"score":0.39169999957084656},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.37279999256134033},{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.3517000079154968},{"id":"https://openalex.org/C69357855","wikidata":"https://www.wikidata.org/wiki/Q163214","display_name":"Diffusion","level":2,"score":0.33160001039505005},{"id":"https://openalex.org/C2777239854","wikidata":"https://www.wikidata.org/wiki/Q902638","display_name":"Excipient","level":2,"score":0.32749998569488525},{"id":"https://openalex.org/C2778370115","wikidata":"https://www.wikidata.org/wiki/Q2038676","display_name":"Stratum corneum","level":2,"score":0.3249000012874603},{"id":"https://openalex.org/C163588942","wikidata":"https://www.wikidata.org/wiki/Q5165929","display_name":"Controlled release","level":2,"score":0.31949999928474426},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.3190999925136566},{"id":"https://openalex.org/C2775842315","wikidata":"https://www.wikidata.org/wiki/Q1145270","display_name":"Transdermal patch","level":3,"score":0.30809998512268066},{"id":"https://openalex.org/C2776711897","wikidata":"https://www.wikidata.org/wiki/Q5974727","display_name":"Liberation","level":3,"score":0.30070000886917114},{"id":"https://openalex.org/C127172972","wikidata":"https://www.wikidata.org/wiki/Q128709","display_name":"Viscosity","level":2,"score":0.2989000082015991},{"id":"https://openalex.org/C14029885","wikidata":"https://www.wikidata.org/wiki/Q5282807","display_name":"Dissolution testing","level":4,"score":0.28189998865127563},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.2777999937534332},{"id":"https://openalex.org/C2778722691","wikidata":"https://www.wikidata.org/wiki/Q57055","display_name":"Acetaminophen","level":2,"score":0.267300009727478},{"id":"https://openalex.org/C101335993","wikidata":"https://www.wikidata.org/wiki/Q408943","display_name":"Poloxamer","level":4,"score":0.26159998774528503},{"id":"https://openalex.org/C2781218482","wikidata":"https://www.wikidata.org/wiki/Q724426","display_name":"Hydroxypropyl cellulose","level":3,"score":0.25859999656677246},{"id":"https://openalex.org/C136229726","wikidata":"https://www.wikidata.org/wiki/Q327092","display_name":"Biomedical engineering","level":1,"score":0.2524000108242035},{"id":"https://openalex.org/C2778201750","wikidata":"https://www.wikidata.org/wiki/Q2602750","display_name":"Diflunisal","level":2,"score":0.2515999972820282},{"id":"https://openalex.org/C3017647366","wikidata":"https://www.wikidata.org/wiki/Q7193459","display_name":"Pig skin","level":2,"score":0.2506999969482422}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1007/s11095-026-04234-w","doi":"https://doi.org/10.1007/s11095-026-04234-w","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11095-026-04234-w","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11095-026-04234-w.pdf","source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},{"id":"pmid:43004086","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/43004086","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s11095-026-04234-w","doi":"https://doi.org/10.1007/s11095-026-04234-w","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11095-026-04234-w","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11095-026-04234-w.pdf","source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225620330.pdf","grobid_xml":"https://content.openalex.org/works/W7225620330.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W1982717414","https://openalex.org/W1989701345","https://openalex.org/W1990484210","https://openalex.org/W2006749540","https://openalex.org/W2017304504","https://openalex.org/W2031679619","https://openalex.org/W2034922414","https://openalex.org/W2059674127","https://openalex.org/W2083550129","https://openalex.org/W2106128515","https://openalex.org/W2141517515","https://openalex.org/W2539107597","https://openalex.org/W2775215939","https://openalex.org/W2783724861","https://openalex.org/W2789676543","https://openalex.org/W2896918429","https://openalex.org/W2956338813","https://openalex.org/W3110985523","https://openalex.org/W3136669999","https://openalex.org/W3201101176","https://openalex.org/W4296952051","https://openalex.org/W4308834590","https://openalex.org/W4361007059","https://openalex.org/W4390114258","https://openalex.org/W4392506638","https://openalex.org/W4396241928","https://openalex.org/W4399916096","https://openalex.org/W4412585503","https://openalex.org/W4415055783","https://openalex.org/W7135407861","https://openalex.org/W7196944430"],"related_works":["https://openalex.org/W4401282750","https://openalex.org/W4225081556","https://openalex.org/W7211938280","https://openalex.org/W7224455151","https://openalex.org/W2555741762","https://openalex.org/W3137840204","https://openalex.org/W2015016370","https://openalex.org/W7215981606","https://openalex.org/W2911013699","https://openalex.org/W3205515107"],"abstract_inverted_index":{"PURPOSE:":[0],"Acetaminophen":[1],"(ACM)":[2],"and":[3,15,38,43,55,61,64,70,80,97,100,104,123,193,199,205,210],"caffeine":[4],"(CAF)":[5],"are":[6],"frequently":[7],"co\u2011administered":[8],"for":[9,13,170,178],"rapid":[10],"analgesic":[11],"relief":[12],"migraines,":[14],"transdermal":[16],"delivery":[17,207],"of":[18,36,77,106,176,184],"these":[19],"over-the-counter":[20],"therapies":[21],"could":[22],"improve":[23],"the":[24,34,92,107],"patient":[25],"at-home":[26],"experience.":[27],"In":[28],"this":[29],"2-part":[30],"series":[31],"we":[32,51],"examine":[33],"impact":[35],"formulation":[37],"physical":[39],"enhancements":[40],"on":[41,112,186,190],"ACM":[42,60,204],"CAF":[44,62,206],"skin":[45,141],"transport.":[46],"Here":[47],"in":[48,156],"part":[49],"1,":[50],"examined":[52],"how":[53],"polymer":[54,158],"solid":[56,211],"microneedle":[57,145],"pretreatment":[58,166],"influence":[59],"release":[63,122],"dermal":[65],"permeation":[66,124,169,187],"from":[67,129],"hydroxyethyl":[68],"cellulose":[69],"polyvinylpyrrolidone":[71],"gels.":[72,134,182],"Part":[73],"2":[74],"examines":[75],"impacts":[76],"dissolving":[78],"microneedles":[79],"applied":[81],"heat.":[82],"METHODS:":[83],"FTIR":[84,148],"was":[85,188],"used":[86],"to":[87,119],"assess":[88],"potential":[89],"interactions":[90],"between":[91],"active":[93],"pharmaceutical":[94],"ingredients":[95],"(APIs)":[96],"polymers.":[98],"Viscosity":[99],"viscoelastic":[101],"parameters":[102],"(G'":[103],"G\u2033)":[105],"polymeric":[108],"gels":[109],"were":[110,117],"measured":[111,140],"a":[113],"rheometer.":[114],"Diffusion":[115],"studies":[116,139],"performed":[118],"quantify":[120],"API":[121],"through":[125],"dermatomed":[126],"porcine":[127],"skin,":[128],"single":[130],"or":[131],"dual-API":[132],"loaded":[133],"Transepidermal":[135],"water":[136],"loss":[137],"(TEWL)":[138],"barrier":[142],"disruption":[143],"after":[144],"application.":[146],"RESULTS:":[147],"confirmed":[149],"that":[150],"both":[151],"drugs":[152],"remained":[153],"chemically":[154],"unchanged":[155],"each":[157],"matrix,":[159],"indicating":[160],"no":[161],"strong":[162],"drug-polymer":[163],"interactions.":[164],"Microneedle":[165],"significantly":[167],"enhanced":[168],"all":[171,202],"formulations,":[172],"with":[173],"varying":[174],"levels":[175],"enhancement":[177],"individual":[179],"vs":[180],"co\u2011API":[181],"Impact":[183],"co-delivery":[185],"dependent":[189],"API,":[191],"polymer,":[192],"timing.":[194],"CONCLUSIONS:":[195],"Polymer":[196],"structure,":[197],"co-delivery,":[198],"microchannel\u2011mediated":[200],"transport":[201],"influenced":[203],"across":[208],"intact":[209],"microneedle-treated":[212],"skin.":[213]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}